| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| R&D Expense | $37K | — | -48.6% |
| SG&A Expense | $186K | — | -47.3% |
| Operating Income | -$223K | — | +47.5% |
| Interest Expense | $3K | — | — |
| Net Income | -$229K | — | +46.6% |
| EPS (Basic) | $0.01 | — | -50.0% |
| EPS (Diluted) | $0.01 | — | -50.0% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Current Assets | $1K | -98.0% | -98.9% |
| Total Assets | $3K | -94.3% | -96.8% |
| Current Liabilities | $1.7M | +12.0% | +101.3% |
| Stockholders' Equity | -$1.7M | -16.0% | -126.4% |
| Line Item | 2026-03-31 | Q/Q | Y/Y |
|---|---|---|---|
| Operating Cash Flow | -$44K | — | +78.9% |
| Financing Cash Flow | $240K | — | +0.0% |